BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11319295)

  • 1. Fractionated doses of oral etoposide in the treatment of patients with aids-related kaposi sarcoma: a clinical and pharmacologic study to improve therapeutic index.
    Sprinz E; Caldas AP; Mans DR; Cancela A; DiLeone L; Dalla Costa T; Schwartsmann G
    Am J Clin Oncol; 2001 Apr; 24(2):177-84. PubMed ID: 11319295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
    Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
    J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
    Remick SC; Reddy M; Ekman K; Vyzula R; Hilstro J; Horton J
    J Infus Chemother; 1996; 6(2):92-6. PubMed ID: 8809657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
    Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
    Gill PS; Espina BM; Muggia F; Cabriales S; Tulpule A; Esplin JA; Liebman HA; Forssen E; Ross ME; Levine AM
    J Clin Oncol; 1995 Apr; 13(4):996-1003. PubMed ID: 7707129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-cis-retinoic acid capsules in the treatment of AIDS-related Kaposi sarcoma: results of a phase 2 multicenter clinical trial.
    Aboulafia DM; Norris D; Henry D; Grossman RJ; Thommes J; Bundow D; Yocum RC; Stevens V
    Arch Dermatol; 2003 Feb; 139(2):178-86. PubMed ID: 12588223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.
    Waits TM; Johnson DH; Hainsworth JD; Hande KR; Thomas M; Greco FA
    J Clin Oncol; 1992 Feb; 10(2):292-6. PubMed ID: 1310104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Lim ST; Tupule A; Espina BM; Levine AM
    Cancer; 2005 Jan; 103(2):417-21. PubMed ID: 15578686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of pentosan polysulfate (PPS) in patients with AIDS-related Kaposi's sarcoma.
    Schwartsmann G; Sprinz E; Kalakun L; Yamagushi N; Sander E; Grivicich I; Koya R; Mans DR
    Tumori; 1996; 82(4):360-3. PubMed ID: 8890970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
    Aita P; Robieux I; Sorio R; Tumolo S; Corona G; Cannizzaro R; Colussi AM; Boiocchi M; Toffoli G
    Cancer Chemother Pharmacol; 1999; 43(4):287-94. PubMed ID: 10071979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma.
    Schwartsmann G; Sprinz E; Kronfeld M; Vinholes J; Sander E; Zampese M; Preger R; Kalakun L; Brunetto AL
    Eur J Cancer; 1991; 27(12):1637-9. PubMed ID: 1782075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer.
    Miller AA; Tolley EA; Niell HB
    Clin Cancer Res; 1998 Jul; 4(7):1705-10. PubMed ID: 9676845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
    Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
    J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic approach to compare oral and i.v. administration of etoposide.
    Würthwein G; Krümpelmann S; Tillmann B; Real E; Schulze-Westhoff P; Jürgens H; Boos J
    Anticancer Drugs; 1999 Oct; 10(9):807-14. PubMed ID: 10587290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.